Jing Gao

Dr. Jing Gao


Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 August 2024 in Nature Communications
Verified
Journal Article
Open access
PDF file
JGJing Gao
Jing Gao
XJXingyu Jiang
Xingyu Jiang
SLShumin Lei
Shumin Lei
WCWenhao Cheng
Wenhao Cheng
YLYi Lai
Yi Lai
ZXZhiai Xu
Zhiai Xu
The antitumor performance of PROteolysis-TArgeting Chimeras (PROTACs) is limited by its insufficient tumor specificity and poor pharmacokinetics. These disadvantages are further compounded by tumor heterogeneity, especially the presence of cancer stem-like cells, which drive tumor growth and relapse. Herein, we design a region-confined PROTAC nanoplatform that integrates both reactive oxygen species (ROS)-activatable and hypoxia-responsive PROTAC prodrugs for the precise manipulation of bromodomain and extraterminal protein 4 expression and tumor eradication. These PROTAC nanoparticles selectively accumulate within and penetrate deep into tumors via response to matrix metalloproteinase-2. Photoactivity is then reactivated in response to the acidic intracellular milieu and the PROTAC is discharged due to the ROS generated via photodynamic therapy specifically within the normoxic microenvironment. Moreover, the latent hypoxia-responsive PROTAC prodrug is restored in hypoxic cancer stem-like cells overexpressing nitroreductase. Here, we show the ability of region-confined PROTAC nanoplatform to effectively degrade BRD4 in both normoxic and hypoxic environments, markedly hindering tumor progression in breast and head-neck tumor models.

18 May 2018 in ACS Biomaterials Science & Engineering
Verified
Journal Article
Closed access
RYRui Yang
Rui Yang
WMWei-Yu Mu
Wei-Yu Mu
QCQiuyun Chen
Qiuyun Chen
QWQiang Wang
Qiang Wang
JGJing Gao
Jing Gao

24 February 2023 in Food & Function
Verified
Journal Article
Closed access
PDF file
QMQingqing Ma
Qingqing Ma
JGJing Gao
Jing Gao
QFQiang Fan
Qiang Fan
TYTao Yang
Tao Yang
ZZZhuang Zhao
Zhuang Zhao
JLJiangang Long
Jiangang Long
Apple polyphenols exert neuroprotective effects by improving the mitochondrial tricarboxylic acid (TCA) cycle function, but the details of their mechanisms are still not fully understood. TCA cycle metabolites regulate the level of 5-hydroxymethylcytosine (5hmC) by affecting the ten-eleven translocation (TET) enzyme activity. Therefore, we hypothesized that thinned young apple polyphenols (TYAPs) inhibit neuronal apoptosis by up-regulating the level of 5hmC in the cerebral cortex of high-fat diet-induced diabetic mice. C57BL/6J mice were randomly divided into 5 groups (n = 10 each group): the control (CON) group, the high-fat diet (HFD, negative control) group, the lovastatin (LOV, positive drug control) group, the resveratrol (RES, positive polyphenol control) group and the TYAP group during an eight-week intervention. The presented results verified that in the HFD group, the level of 5hmC and the expression of TET2 in the cerebral cortex were significantly lower, and the ratio of (succinic acid + fumaric acid)/α-ketoglutarate and the neuronal apoptosis rate were significantly higher than those in the CON group. However, TYAP intervention effectively restored the level of 5hmC through up-regulating the expression and activity of TET2, so as to improve diabetes symptoms and prevent diabetes-induced neuronal apoptosis.

11 January 2023 in Antioxidants
Verified
Journal Article
Open access
PDF file
xuyun liuxuyun liu
xuyun liu
JGJing Gao
Jing Gao
YYYizhen Yan
Yizhen Yan
EGeleftheria Georgiou
eleftheria Georgiou
JLJing Lou
Jing Lou
LZLin Zhao
Lin Zhao
Hyperlipidemia results in endothelial dysfunction, which is intimately associated with disturbed mitochondrial homeostasis, and is a real risk factor for cardiovascular diseases (CVDs). Triphenylphosphonium (TPP+)-HT, constructed by linking a mitochondrial-targeting moiety TPP+ to hydroxytyrosol (HT), enters the cell and accumulates in mitochondria and is thus an important candidate drug for preventing hyperlipidemia-induced endothelial injury. In the present study, we found that TPP-HT has a better anti-inflammatory effect than HT. In vivo, TPP-HT significantly prevented hyperlipidemia-induced adverse changes in the serological lipid panel, as well as endothelial and mitochondrial dysfunction of the thoracic aorta. Similarly, in vitro, TPP-HT exhibited similar protective effects in palmitate (PA)-induced endothelial dysfunction, particularly enhanced expression of the mitochondrial ETC complex II, recovered FoxO1 expression in PA-injured human aorta endothelial cells (HAECs) and promoted FoxO1 nuclear translocation. We further demonstrated that FoxO1 plays a pivotal role in regulating ATP production in the presence of TPP-HT by using the siFoxO1 knockdown technique. Simultaneously, TPP-HT enhanced Nrf2 nuclear translocation, consistent with the in vivo findings of immunofluorescence, and the antioxidant effect of TPP-HT was almost entirely blocked by siNrf2. Concomitantly, TPP-HT’s anti-inflammatory effects in the current study were primarily mediated via the p38 MAPK/NF-κB signaling pathway in addition to the FoxO1 and Nrf2 pathways. In brief, our findings suggest that mitochondria-targeted TPP-HT prevents lipotoxicity induced endothelial dysfunction by enhancing mitochondrial function and redox balance by promoting FoxO1 and Nrf2 nuclear translocation.

28 August 2020 in Cell Research
Verified
Journal Article
Open access
PDF file
JLJing Liu
Jing Liu
YPYunhua Peng
Yunhua Peng
LSLe Shi
Le Shi
Lixin WanLixin Wan
Lixin Wan
HIHiroyuki Inuzuka
Hiroyuki Inuzuka
WWWenyi Wei
Wenyi Wei
An amendment to this paper has been published and can be accessed via a link at the top of the paper.

28 November 2012
Verified
Book Chapter
Closed access
PDF file
QMQi Ma
Qi Ma
YYYang-Feng Yang
Yang-Feng Yang
JGJing Gao
Jing Gao
LRLu Ren
Lu Ren
WZWenyu Zhang
Wenyu Zhang